New eye drop combo may offer Round-the-Clock glaucoma relief
NCT ID NCT07325240
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a combination eye drop (Rocklatan) works better than a standard drop (Latanoprost) at lowering eye pressure over a full 24-hour period in adults with open-angle glaucoma or ocular hypertension. About 30 participants will use one drop in each eye nightly. The goal is to see which provides more consistent pressure control, day and night.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new eye test match the gold standard for glaucoma?
- Which laser best tames glaucoma pressure?
- Could a single eye implant replace years of glaucoma drops?
- Which eye implant best tames glaucoma? a head-to-head trial aims to find out.
- One drop before the laser: could this simple step save your sight?
- Eye implant could offer long-term pressure control for glaucoma patients